INS and metabolic dysfunction-associated steatotic liver disease: After treatment with MSC exosomes, the levels of blood glucose and insulin, volume of visceral fat, number of lipid droplets, ballooning degeneration in liver tissue, and NAFLD activity score decreased in NASH mice.